H3.3 safeguards haematopoietic ERV-quilibrium

Nat Cell Biol. 2022 Jan;24(1):7-9. doi: 10.1038/s41556-021-00758-y.

Nadia Omega Cipta^{1

2}, Ying Chen^{1

3}, Yuin-Han Loh^{4

5

6

7}

¹ Cell Fate Engineering and Therapeutics Laboratory, A*STAR Institute of Molecular and Cell Biology, Singapore, Singapore.
² Department of Biological Sciences, National University of Singapore, Singapore, Singapore.
³ NUS Graduate School for Integrative Sciences and Engineering Programme, National University of Singapore, Singapore, Singapore.
⁴ Cell Fate Engineering and Therapeutics Laboratory, A*STAR Institute of Molecular and Cell Biology, Singapore, Singapore. yhloh@imcb.a-star.edu.sg.
⁵ Department of Biological Sciences, National University of Singapore, Singapore, Singapore. yhloh@imcb.a-star.edu.sg.
⁶ NUS Graduate School for Integrative Sciences and Engineering Programme, National University of Singapore, Singapore, Singapore. yhloh@imcb.a-star.edu.sg.
⁷ Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. yhloh@imcb.a-star.edu.sg.

No abstract available

Publication types